Reilly Financial Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Reilly Financial Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-500	Closed	-$29K	–	993
2019 Q2	$29K	Hold	500	–	–	﹤0.01%	460
2019 Q1	$22K	Hold	500	–	–	﹤0.01%	516
2018 Q4	$19K	Hold	500	–	–	﹤0.01%	511
2018 Q3	$23K	Hold	500	–	–	﹤0.01%	524
2018 Q2	$22K	Hold	500	–	–	﹤0.01%	479
2018 Q1	$20K	Hold	500	–	–	﹤0.01%	500
2017 Q4	$17K	Hold	500	–	–	﹤0.01%	550
2017 Q3	$13K	Hold	500	–	–	﹤0.01%	592
2017 Q2	$8K	Hold	500	–	–	﹤0.01%	696
2017 Q1	$7K	Hold	500	–	–	﹤0.01%	687
2016 Q4	$7K	Hold	500	–	–	﹤0.01%	620
2016 Q3	$9K	Buy	500 +300	+150%	+$4.97K	﹤0.01%	557
2016 Q2	$3K	Hold	200	–	–	﹤0.01%	695
2016 Q1	$4K	Buy	+200	New	+$3.21K	﹤0.01%	977
2015 Q4	–	Sell	-50	Closed	-$1K	–	1426
2015 Q3	$1K	Hold	50	–	–	﹤0.01%	1227
2015 Q2	$2K	Hold	50	–	–	﹤0.01%	1243
2015 Q1	$2K	Hold	50	–	–	﹤0.01%	1190
2014 Q4	$2K	Buy	+50	New	+$2.03K	﹤0.01%	772

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Reilly Financial Advisors's ARNA Position: Q3 2019 in Review

Reilly Financial Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2019, closing a stake of 500 shares — an estimated $29K sold.

Reilly Financial Advisors first reported a position in ARNA in Q4 2014 and held it in 18 quarters. The position peaked at $29K in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

Reilly Financial Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2019 after selling out during the quarter.
Reilly Financial Advisors sold 500 Arena Pharmaceuticals Inc shares in Q3 2019, an estimated $29K.
Reilly Financial Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2014 and held it in 18 quarters.
Reilly Financial Advisors's Arena Pharmaceuticals Inc position peaked at $29K in Q2 2019.
230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Reilly Financial Advisors's 13F filing for Q3 2019, filed 15 Oct 2019.